PRESS DIGEST-Financial Times - April 30

* AstraZeneca is to ⁠resume ​the expansion of its research and development operations in Cambridge, and would invest 300 million pounds ($403.74 million) to complete the Rosalind ⁠Franklin building that it put on pause last year. * Irish Energy ⁠distributor DCC said ⁠it is reviewing a cash takeover proposal from a consortium comprising U.S. investment firms Energy Capital Partners ‌and ‌KKR.

The following are the ​top stories in the Financial ​Times. Reuters has not ‌verified these ​stories and does not vouch for their accuracy. Headlines

* EU in talks with Hungary’s ‌Péter Magyar on workaround for frozen funds * Bank of England in stand-off with FCA over trading firms’ capital

* AstraZeneca revives Cambridge investment ‌after UK agrees to pay more for drugs * DCC considers takeover ‌bid from KKR and Energy Capital

Overview * The European Union is negotiating with Peter Magyar, Hungary’s incoming prime minister, a workaround to keep part of 10 ⁠billion ​euros ($11.66 billion) ⁠in frozen Covid-19 pandemic recovery funds available beyond an August deadline.

* The Bank ⁠of England has raised concerns over plans by the Financial Conduct Authority ​to cut the capital requirements of specialist trading firms such ⁠as Citadel Securities, Jane Street and Hudson River Trading. * AstraZeneca is to ⁠resume ​the expansion of its research and development operations in Cambridge, and would invest 300 million pounds ($403.74 million) to complete the Rosalind ⁠Franklin building that it put on pause last year.

* Irish Energy ⁠distributor DCC said ⁠it is reviewing a cash takeover proposal from a consortium comprising U.S. investment firms Energy Capital Partners ‌and ‌KKR. ($1 = 0.8574 euros)

($1 = 0.7431 pounds) (Compiled ​by Bengaluru newsroom)